GlassScriptPhysician profile
Vincent Lusco
NPI 1508868753
$4,735.46
in general payments reported to CMS, 2019-2025
36 companies · $373 in 2025
The $373 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $724 · 2020: $25.54 · 2021: $489 · 2022: $1,295 · 2023: $1,271 · 2024: $557 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,201.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reshape Lifesciences INC. | $1,608.04 | 2019-2023 | |
| Davol INC. | $619.96 | 2022-2025 | Phasix Mesh, Ventralight St |
| Novo Nordisk INC | $298.57 | 2022-2023 | Wegovy |
| Kerecis Limited | $219.80 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Vertex Pharmaceuticals Incorporated | $204.02 | 2025 | |
| Tela Bio, INC. | $193.51 | 2020-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $164.43 | 2019-2025 | Echelon Flex, Surgiflo Hemostatic Matrix, Stratafix |
| Stryker Corporation | $150.00 | 2022 | |
| Phathom Pharmaceuticals, INC. | $141.21 | 2024 | Voquezna |
| Organogenesis INC. | $127.26 | 2022-2024 | |
| Acacia Pharma INC | $122.76 | 2021 | |
| Intuitive Surgical, INC. | $109.55 | 2019-2022 | |
| Integra Lifesciences Corporation | $109.36 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Pacira Pharmaceuticals Incorporated | $88.92 | 2021 | |
| Innovation Technologies INC | $66.35 | 2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $53.06 | 2023-2024 | Restrata Wound Matrix |
| Paratek Pharmaceuticals, INC. | $46.45 | 2023 | Nuzyra |
| Aroa Biosurgery Incorporated | $42.58 | 2019 | |
| Smith+Nephew, INC. | $39.86 | 2024 | Renasys Touch, Pico 7 |
| Medtronic, INC. | $33.41 | 2024-2025 | Maxtack, Tacker |
| Sanara Medtech INC. | $24.62 | 2022 | |
| Hologic Sales and Service, LLC | $24.41 | 2025 | Coolseal Generator |
| Ambu INC. | $23.48 | 2022 | |
| Daiichi Sankyo INC. | $22.59 | 2022 | |
| Innocoll Pharmaceuticals Limited | $21.58 | 2021 | |
| Baxter Healthcare | $21.29 | 2024 | Perclot |
| Polynovo North America LLC | $21.27 | 2025 | Novosorb Btm |
| Braintree Laboratories, INC. | $20.42 | 2021 | |
| Abbvie INC. | $19.21 | 2023 | |
| W. L. Gore & Associates, INC. | $18.33 | 2023 | Seamguard |
| Tetraphase Pharmaceuticals, INC. | $16.00 | 2019 | |
| Avanos Medical | $13.94 | 2022 | |
| Bioventus LLC | $13.61 | 2023 | Sonicone Clinic |
| Melinta Therapeutics, LLC | $12.36 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.65 | 2022 | |
| Olympus America INC. | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Lusco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.